IL161991A0 - Oral dosage form of a sulfonamide prodrug such as parecoxib - Google Patents

Oral dosage form of a sulfonamide prodrug such as parecoxib

Info

Publication number
IL161991A0
IL161991A0 IL16199102A IL16199102A IL161991A0 IL 161991 A0 IL161991 A0 IL 161991A0 IL 16199102 A IL16199102 A IL 16199102A IL 16199102 A IL16199102 A IL 16199102A IL 161991 A0 IL161991 A0 IL 161991A0
Authority
IL
Israel
Prior art keywords
parecoxib
dosage form
oral dosage
sulfonamide
prodrug
Prior art date
Application number
IL16199102A
Other languages
English (en)
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of IL161991A0 publication Critical patent/IL161991A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16199102A 2001-11-13 2002-11-12 Oral dosage form of a sulfonamide prodrug such as parecoxib IL161991A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35059601P 2001-11-13 2001-11-13
PCT/US2002/036253 WO2003041705A1 (en) 2001-11-13 2002-11-12 Oral dosage form of a sulfonamide prodrug such as parecoxib

Publications (1)

Publication Number Publication Date
IL161991A0 true IL161991A0 (en) 2005-11-20

Family

ID=23377399

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16199102A IL161991A0 (en) 2001-11-13 2002-11-12 Oral dosage form of a sulfonamide prodrug such as parecoxib

Country Status (20)

Country Link
US (1) US20030100595A1 (es)
EP (1) EP1446118B1 (es)
JP (1) JP2005509002A (es)
KR (1) KR20050044459A (es)
CN (1) CN1615135A (es)
AR (1) AR037356A1 (es)
AT (1) ATE383156T1 (es)
BR (1) BR0214081A (es)
CA (1) CA2466504A1 (es)
CO (1) CO5580744A2 (es)
DE (1) DE60224558T2 (es)
ES (1) ES2297032T3 (es)
IL (1) IL161991A0 (es)
MX (1) MXPA04004476A (es)
NO (1) NO20042440L (es)
PL (1) PL369962A1 (es)
RU (1) RU2004114552A (es)
TW (1) TW200300680A (es)
WO (1) WO2003041705A1 (es)
ZA (1) ZA200403328B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785640B2 (en) * 2004-01-16 2010-08-31 Amerilab Technologies, Inc. Effervescent composition including cranberry extract
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
US7964223B2 (en) * 2005-09-27 2011-06-21 University Of Kentucky Research Foundation Berry preparations and extracts
WO2007042035A2 (en) * 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
US20100047371A1 (en) * 2006-08-29 2010-02-25 Mumper Russell J Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
ES2377426T3 (es) * 2007-10-12 2012-03-27 Astrazeneca Ab Composición de zibotentán que contiene manitol y celulosa microcristalina
US8906420B2 (en) 2009-01-09 2014-12-09 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
JP6102120B2 (ja) * 2012-08-16 2017-03-29 ニプロ株式会社 医薬製剤およびその製造方法
CN104771370B (zh) * 2014-01-14 2020-07-24 南京圣和药业股份有限公司 帕瑞昔布钠冻干粉针剂及其制备方法
CN104965041B (zh) * 2015-06-11 2016-06-29 成都克莱蒙医药科技有限公司 一种帕瑞昔布钠异构体的高效液相色谱检测方法
CN106074399B (zh) * 2016-06-21 2018-11-02 马鞍山丰原制药有限公司 一种帕瑞昔布钠冻干制剂及其制备方法
CN112409283A (zh) * 2020-11-24 2021-02-26 苏州璞正医药有限公司 一种帕瑞昔布衍生物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013794A1 (fr) * 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Procede pour produire une composition de medicament stable, et preparation pharmaceutique
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
EP0892791B1 (en) * 1996-04-12 2003-03-05 G.D. Searle & Co. N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
US6323226B1 (en) * 1999-10-19 2001-11-27 Texas Heart Institute Treatment of heart disease with cox-2 inhibitors
JP2003516353A (ja) * 1999-12-08 2003-05-13 ファルマシア コーポレイション ヴァルデコキシブ組成物
MY127898A (en) * 1999-12-22 2006-12-29 Pharmacia Corp Dual-release compositions of a cyclooxygenase-2 inhibitor
US6403830B2 (en) * 2000-03-24 2002-06-11 Pharmacia Corporation Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
MY120279A (en) * 2000-05-26 2005-09-30 Pharmacia Corp Use of a celecoxib composition for fast pain relief
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
JP2004503588A (ja) * 2000-07-13 2004-02-05 ファルマシア・コーポレーション 全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−2阻害薬および血管調節化合物
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition

Also Published As

Publication number Publication date
EP1446118B1 (en) 2008-01-09
ATE383156T1 (de) 2008-01-15
EP1446118A1 (en) 2004-08-18
AR037356A1 (es) 2004-11-03
DE60224558T2 (de) 2009-01-22
CO5580744A2 (es) 2005-11-30
JP2005509002A (ja) 2005-04-07
WO2003041705A1 (en) 2003-05-22
DE60224558D1 (de) 2008-02-21
KR20050044459A (ko) 2005-05-12
ZA200403328B (en) 2005-04-13
ES2297032T3 (es) 2008-05-01
MXPA04004476A (es) 2004-08-11
TW200300680A (en) 2003-06-16
PL369962A1 (en) 2005-05-02
CN1615135A (zh) 2005-05-11
CA2466504A1 (en) 2003-05-22
NO20042440L (no) 2004-08-09
RU2004114552A (ru) 2005-02-20
US20030100595A1 (en) 2003-05-29
BR0214081A (pt) 2004-09-28

Similar Documents

Publication Publication Date Title
PL356358A1 (en) Solid dosage form of someticone for oral administration
HK1064035A1 (en) Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
PL367180A1 (en) Stabilized oral pharmaceutical composition
AU2002301259A1 (en) Simethicone solid oral dosage form
EP1407785A4 (en) MEDICAL COMPOSITIONS
HK1065944A1 (en) Medicinal compositions
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
HUP0400850A3 (en) Oral pharmaceutical compositions
IL161991A0 (en) Oral dosage form of a sulfonamide prodrug such as parecoxib
EP1532971A4 (en) PREPARATIONS FOR THE ORAL CAVITY
IL166337A0 (en) Oral administration of calctionin
GB2383989B (en) Improved oral medicine dispenser
IL161143A0 (en) A flash-melt pharmaceutical oral dosage composition
GB0126244D0 (en) Oral compositions
IS7219A (is) Lyfjablanda sem inniheldur (R) -bíkalútamíð
IL160371A0 (en) A new extended release oral dosage form
PL369268A1 (en) A stable pharmaceutical composition of pravastatin
EP1357898A4 (en) ORAL DOSAGE FORM WITH ENHANCED REGULATED RELEASE
AU2003263480A8 (en) Oral pharmaceutical compositions of fenofibrate having high bioavailability
AU2002313628A1 (en) Tamper resistant oral dosage form
AU2002343538A1 (en) Oral delivery of a botanical
HUP0401587A3 (en) A new extended release oral dosage form
AU2002327993A1 (en) A new extended release oral dosage form
GB0224762D0 (en) Development of a novel strategy for the prevention of dental caries
AU2002330729A1 (en) Oral controlled release pharmaceutical composition of a prokinetic agent